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The radiation dose-rate effect in two human neuroblastoma cell lines
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Summary The current use of targeted radiotherapy in the treatment of neuroblastoma has generated a
requirement for further information on the radiobiology of these cells. Here we report on studies of the
dose-rate effect in two human neuroblastoma cell lines (HX138 and HX142) and the recovery that they
demonstrate in split-dose experiments. The sensitivity of the two cell lines to high dose-rate irradiation was
confirmed. Surviving fractions at 2 Gy were 0.083 for HX138 anc' 0.11 for HX142. There was little evidence of
a dose-rate effect above 2 cGy min-' but significant sparing was seen at lower dose rates. Substantial recovery
was seen in split-dose experiments on both cell lines, to an extent that was consistent with the linear quadratic
equation. The data were used to derive values for the P parameter of the linear-quadratic equation; the values
for the neuroblastomas were higher than for any of the other human tumour cell lines that we have
investigated to date. Thus, despite their high sensitivity to ionising radiation HX138 and HX142 do exhibit
substantial levels of cellular recovery, suggesting that they may have a significant capacity for repair of
radiation-induced lesions.
Human neuroblastoma is a childhood tumour which is
generally regarded as being radioresponsive even though
external-beam radiotherapy plays a minor role in its manage-
ment (Jacobson et al., 1983). As a result of the relatively
specific uptake into these tumours of MIBG, the treatment of
patients with systemically-administered '1I-MIBG is increas-
ingly being performed (Pinkerton, 1990). There is therefore a
need for more detailed understanding of the response to
ionising radiation in neuroblastoma.
Recent work in this department has drawn attention to the
fact that radiosensitive human tumour cells may not be
recovery-deficient (Peacock et al., 1988) and that radiation
split-dose recovery increases continuously with dose. We
have therefore set out in this study to compare the results of
low dose-rate and multiple-dose-level split-dose experiments
in two neuroblastoma cell lines. This is the final report of a
project from which parts of the data have appeared in an
interim form (Peacock et al., 1988, McMillan et al., 1989).
tubes (Falcon). After allowing the agar to set on ice, the
cultures were gassed in a 3%, 02, 5% CO2, 92% N2 at-
mosphere for a minimum of 2 hours and sealed.
All irraditions were carried out in portable perspex
incubators at 37°C using a 1,250Ci 'Co source for dose
rates of 20-90 cGy min-' and a 54 Ci 'Co source for dose-
rates of l-lOcGymin-'. Dose rates of 0.5 and
0.25 cGy min' were achieved using a 6Ci '37Cs source. On
completion of the radiation treatment, cultures were fed with
fresh medium and incubated for 21 days. Colonies exceeding
50 cells were then counted under an inverted microscope by
decanting the agar pellet onto a glass slide and covering with
a 50 mm glass coverslip. Mean control plating efficiencies
were 0.17 for HX138 and 0.30 for HX142.
Comparison of the data with mathematical models was





The two cell lines used here, HX138 and HX142 were estab-
lished from xenografted tumour tissue by Dr J.M. Deacon in
this department (Deacon, 1987). After a period of growth as
floating aggregates each is now established as a monolayer
cell line.
Cultures were maintained in Ham's F12 medium (Gibco)
supplemented with antibiotics (penicillin 100pgml-' and
streptomycin 0.1 mg ml-') and 10% fetal calf serum
(Imperial Laboratories) in a low oxygen atmosphere (3% 02,
5% C02, 92% N2).
Clonogenic cell survival and irradiations
Cell survival assays were carried out according to the soft
agar colony method of Courtenay and Mills (1978). Briefly,
single-cell suspensions were prepared from stock cultures by
enzymatic digestion (trypsin 0.05%:EDTA 0.02%). Serial
dilutions were made on the basis of haemocytometer counts.
One ml aliquots of a mixture of 2 volumes tumour cell
suspension, I volume August Rat red blood cells (diluted 1:8
and irradiated to a dose of approximately 200 Gy), I volume
letha-lly irradiated tumour cells and 6 volumes 0.5% warm
agar (Difco) were then pipetted into round-bottomed culture
Cell survival after single-dose acute irradiation
The high intrinsic cellular radiosensitivity of these two
neuroblastoma cell lines was confirmed (Figure 1). Both lines
show steep survival curves at 90 cGy min-'. In the case of
HX138 the data are indistinguishable from a pure exponen-
tial curve and in HX142 there is evidence for curvature in the
semi-logarithmic plot. The survival at 2 Gy is 0.083 for
HX138 and 0.11 for HX142. When fitted with a linear-
quadratic equation the resulting values for a are large:
1.23Gy-' for HX138 and 0.92Gy-' for HX142 (Table I).
Low dose rate
Data were obtained on HX138 at seven reduced dose rates
(Figure 2). The data sets between 20 and 2 cGy min-' show
very little dose-rate effect but at lower dose rates the data do
diverge from the acute survival curve (shown by the dashed
line). Reproducibility of the data at 0.25 cGy min-' was
poor.
The data on HX142 are at five reduced dose rates (Figure
3). Again, there is little dose-rate effect for rates in excess of
I cGy min-'.
Each set of data has been fitted with the linear quadratic
equation and the resulting parameters are shown in Table I.
Comparison between the cell lines is facilitated by plotting
isoeffect curves; Figure 4 shows the dose (DO.01) required to
produce a surviving fraction of 0.01 as a function of dose
rate.
The data for each cell line have also been fitted using the
incomplete repair model (Thames, 1985). Data at all dose
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Figure I Cell survival curves for HX138 and HX142 irradiated at
high dose-rate (9OcGymin-').
Table I Parameters of linear-quadratic equation fitted to the
survival curves
Dose rate
Cell line (cGy min') a O
HX138 90 1.23 0.0006 0.0068 0.0001
20 0.65 0.15 0.073 0.030
10 1.01 0.22 0.045 0.047
5 0.78 ±0.13 0.085 0.029
2 1.01 0.033 0.0061 0.016
1 0.81 0.006 0.0056 0.022
0.5 0.16 0.26 0.094 ±0.042
0.25 0.98 0.30 - 0.051 0.04
HX142 90 0.92 0.009 0.097 0.008
20 1.28±0.17 0.0013±0.032
2 1.26 0.0003 - 0.006 0.006
1 0.66 0.027 0.051 0.004
0.5 0.66 0.06 0.076 0.008
0.25 1.03 0.10 - 0.03 ±0.02
Units: a Gy-'; P Gy-2. Values are mean ± s.e.
rates were simultaneously fitted by minimising the mean
square deviations of the experimental points from their
respective calculated curve. The resulting parameters are
given in Table II. D0.01 values have also been calculated from
the model and the values of these are shown as the full lines
in Figure 4. It should be stressed that these lines are not
fitted to the points shown in Figure 4 but to all the experi-
mental data. Nevertheless, the agreement between model and
data in each case is reasonably good.
Split-dose recovery
Split-dose experiments were performed on HX138 using an
equal dose split (1 + 1, 2 + 2 Gy, etc.) at a range of dose
levels from 1 to 6 Gy. Results were expressed as recovery
ratio (RR), defined as the ratio of survival from the divided
dose to that of the equivalent single dose. As a function of
the time between doses, RR increased to reach a plateau level
at about 90-120 min. The maximum recovery ratios (RRm.)
were therefore taken as the mean of three values beyond 2
hours.
The linear-quadratic equation predicts that the RRma,
should increase rapidly with dose according to the relation
RRMX= exp (213d2) (Thames, 1985; Steel et al., 1987). The
relationship between RRmai, and 2d2 is plotted in Figure 5 for
HX138 and for HX142 (from Peacock et al., 1988). As
expected from the above equation the results are consistent
with straight lines through the origin (Figure 5). The slope of
these lines gives a value for 13, which (because of its mode of
derivation) we call PRR. Values for PRR are given in Table II.
Table II Summary of survival curve parameters
Acute survival Incomplete Split-dose
curve repair model recovery
Cell line a 1 a p Tt PRR
HX138 1.23 0.007 0.65 0.13 68 0.115
HX142 0.92 0.097 0.90 0.096 73 0.059
Units: aGy'; PGy-2; half-time in minutes.
Discussion
The high radiosensitivity of cell lines derived from human
neuroblastoma has been demonstrated in previous studies
(Ohnuma et al., 1977; Deacon et al., 1985) although it was
not seen in the work of Weichselbaum et al. (1980). For the
cell lines that we have studied the survival curves observed at
high dose rate are comparable to those demonstrated for
transformed fibroblasts from ataxia-telangiectasia patients, a
well established radiosensitive syndrome (McKinnon, 1987;
McMillan et al., 1989). In recent years it has been found that
SF2, the survival for a dose of 2 Gy, is a parameter of
radiosensitivity that is not only clinically relevant but also
shows good discrimination between cell lines (Deacon et al.,
1984; Fertil & Malaise, 1981). The SF2 values for the two cell
lines studied here are 0.083 and 0.11, which places them
among the most radiosensitive human tumour cell lines so far
reported.
On the basis of less complete data we previously concluded
that the HX138 cell line showed no dose-rate effect (Deacon,
1987; Steel et al., 1987). We have now examined the radio-
sensitivity of these cells at eight dose rates down to
0.25 Gy min '. As shown in Figures 2 and 4, there is
evidence at the lower rates for a clear sparing effect. In the
HX142 cell line our data at six dose rates demonstrate a
smaller but distinct sparing effect below 2 cGymin-'.
In order to quantitate the change in cell survival as the
dose-rate is altered we have fitted the data with the incom-
plete repair model described by Thames (1985). This model is
linear-quadratic in form at high dose rate and it incorporates
a parameter which determines the speed with which the
13-component of cell killing disappears after an increment of
radiation exposure, and therefore the kinetics ofthe dose-rate
effect. From this the half time for recovery, T1, can be
derived. It should be emphasised that we are making no
conclusions regarding the mechanisms underlying the
parameters in this model. Rather we are simply using it to
describe the dose-rate effect in these cell lines.
Our data appear to be reasonably consistent with this
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Figure 2 Survival curves for HX138 after irradiation at dose-rates from 20 to 0.25 cGy min-'. The dashed lines represent the acute
survival curve (90 cGy minm ).
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Figure 3 Survival curves for HX142 after irradiation at dose-rates from 20 to 0.25 cGy min- .The dashed lines represent the acute
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Figure 4 Isoeffect curves for HXl38 and HX142 as a function of
dose rate. D001 is the dose to reduce survival to 0.01. The full lines
are calculated using the incomplete repair model, globally fitted to
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Figure 5 A plot of log(RR) against 2d2 for split-dose recovery
experiments on the two neuroblastomas. 0, HX138; 0, HX142.
Data for HX142 are taken from Peacock et al. (1988).
not well fitted. For instance, in HX138 at 20cGy min-'
(Figures 2 and 4) the data suggest a change in sensitivity that
is not confirmed by the trend with dose rate. This analysis
leads to the parameter values shown in Table II. The values
for a and P for HX142 correspond closely to those obtained
by fitting a linear-quadratic equation to the acute survival
data alone. For HX138, there are considerable differences,
the value for a being half the acute survival value. These
differences arise because the acute survival data define an
almost straight survival curve (with P correspondingly low)
but the incomplete repair model requires a slight curvature in
order to model the sparing effect that appears at low dose
rates (in the model the slope of the low dose-rate curve must
extrapolate the initial slope of the acute survival curve).
Which of these two a-values is the more reliable is not clear.
The fit to the acute survival data is subject to problems
because of the trade-off of one parameter in the equation
against the other. On the other hand, the incomplete repair
model separates the parameters more easily but it makes
assumptions regarding the relationship between the shape of
the acute survival curve and the rate and extent of the
dose-rate effect.
The present studies have gone down to lower dose rates
than we have previously used (Steel et al., 1987). The limiting
factor is the need to avoid cell proliferation during radiation
exposure. The population doubling times of untreated
HX138 and HX142 cultures are 24-30 h. Irradiation will
induce growth retardation, and we have therefore reasoned
that an overall exposure time of up to 40 h would be unlikely
to allow more than about one doubling of cell number. The
time taken to deliver 6 Gy in these very radiosensitive cells
was 10h at 1 cGymin-' and 40h at 0.25 cGymin-'. We
cannot rule out the possibility that there may have been a
small effect of cell proliferation at the lowest dose rates;
indeed this may be the reason why for both cell lines the
points in Figure 4 at 0.25 cGy min-' lie above the theoretical
curve and produce negative values for P in the linear quad-
ratic fit. If proliferation does occur, then the progression of
cells through phases of the cell cycle with differing radiosen-
sitivity may also alter the response at low dose-rate. The
effect of this should be to increase sensitivity and therefore is
not likely to increase the dose-rate effect.
Split-dose experiments at multiple dose levels provide an
alternative measure of cellular recovery, as indicated by the 13
parameter in the linear-quadratic equation (Peacock et al.,
1988). Our data obtained in this way were consistent with the
implications of the linear-quadratic equation in showing a
linear increase of log (RR) with 2d2 (Figure 5). This does
not, however, preclude an exponential portion of the curve at
high doses. For HX138 cells the value for PRR thus found was
close to that from the incomplete repair model (Table II).
For HX142 we have previously shown that the values differ
by a factor of 2 (Peacock et al., 1988). If this difference is
real, a possible explanation might be sought in terms of
inducible repair (Friedberg, 1985; Shadley & Wiencke, 1989).
We doubt this, however, because in studies on other human
tumour cell lines there does not appear to be a significant
trend towards the two P values differing in a consistent way.
The values of PRR obtained for these lines are higher than
we have obtained for any of our more resistant human
tumour cell lines (Peacock et al., 1988; Yang et al., 1990).
This shows directly that for any given dose the recovery
observed in a split-dose experiment is greatest in the more
sensitive lines. These sensitive neuroblastoma cell lines are
certainly not recovery deficient and therefore may not be
deficient in repair of DNA lesions. In this regard the neuro-
blastoma cells differ from ataxia telangiectasia fibroblasts
which, although they are similarly radiosensitive, show less
recovery after irradiation than their normal counterpart
(Cox, 1982; Peacock et al., 1989).
The results that we have obtained indicate the contrast
between 'recovery capacity' (which we would identify with
the value of P) and 'dose recovery' in a fractionation or low
dose-rate treatment. Neuroblastoma cells have a high
recovery capacity, but because they have high a values (and
therefore steep survival curves both at high and low dose
rate) we observe low values for dose recovery. This contrast
has been discussed further in a recent review paper (Steel et
al., 1989).
From a mechanistic molecular point of view these results
have important implications. It has until recently been
believed that the major determinant of cellular sensitivity was
repair capacity and this was often inferred from studies of
cellular recovery. We would therefore have expected to find
obvious recovery deficiencies in the neuroblastoma cells. That
this was not the case suggests that recovery and hence repair
is not a major determinant of cellular radiosensitivity.
Measurement of DNA double-strand breaks using neutral
filter elution has suggested that the level of damage initially
induced in DNA by ionising radiation may be an additional
factor (Radford, 1986; McMillan et al., 1989, 1990).
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